These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28069693)

  • 21. Gene rearrangements in radiation-induced thyroid carcinogenesis.
    Rabes HM
    Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].
    Vasil'ev EV; Rumiantsev PO; Saenko VA; Il'in AA; Poliakova EIu; Nemtsova MV; Zaletaev DV
    Mol Biol (Mosk); 2004; 38(4):642-53. PubMed ID: 15456136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
    Brzeziańska E; Karbownik M; Migdalska-Sek M; Pastuszak-Lewandoska D; Włoch J; Lewiński A
    Mutat Res; 2006 Jul; 599(1-2):26-35. PubMed ID: 16483615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.
    Hecht F; Valerio L; Gonçalves CFL; Harinquet M; Ameziane El Hassani R; Carvalho DP; Koundrioukoff S; Cadoret JC; Dupuy C
    Eur Thyroid J; 2024 Aug; 13(4):. PubMed ID: 39047147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of wild-type c-RET and zero prevalence of RET/PTC rearrangements are associated with papillary thyroid cancer (PTC) in Kuwait.
    El-Abdallah AA; Junaid TA
    Exp Mol Pathol; 2011 Feb; 90(1):61-5. PubMed ID: 20950609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma.
    Zhang T; Lu Y; Ye Q; Zhang M; Zheng L; Yin X; Gavine P; Sun Z; Ji Q; Zhu G; Su X
    Genes Chromosomes Cancer; 2015 Mar; 54(3):168-76. PubMed ID: 25407564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma.
    Elisei R; Romei C; Soldatenko PP; Cosci B; Vorontsova T; Vivaldi A; Basolo F; Cherstvoy ED; Pinchera A; Pacini F
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):131-6. PubMed ID: 10931090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.
    Nibu K; Otsuki N; Nakao K; Sugasawa M; Rothstein JL
    Eur Arch Otorhinolaryngol; 2005 May; 262(5):368-73. PubMed ID: 15368067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma.
    Ciampi R; Giordano TJ; Wikenheiser-Brokamp K; Koenig RJ; Nikiforov YE
    Endocr Relat Cancer; 2007 Jun; 14(2):445-52. PubMed ID: 17639057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of RET/PTC1 and RET/PTC3 oncoproteins in radiation-induced papillary thyroid carcinomas on amounts of cytoskeletal protein species.
    Zeindl-Eberhart E; Liebmann S; Jungblut PR; Mattow J; Schmid M; Kerler R; Rabes HM
    Amino Acids; 2011 Jul; 41(2):415-25. PubMed ID: 20839015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
    Zhu XL; Zhou XY; Zhang TM; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.
    Colato C; Vicentini C; Cantara S; Pedron S; Brazzarola P; Marchetti I; Di Coscio G; Chilosi M; Brunelli M; Pacini F; Ferdeghini M
    Eur J Endocrinol; 2015 May; 172(5):571-82. PubMed ID: 25698220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).
    Nakazawa T; Kondo T; Kobayashi Y; Takamura N; Murata S; Kameyama K; Muramatsu A; Ito K; Kobayashi M; Katoh R
    Cancer; 2005 Sep; 104(5):943-51. PubMed ID: 16015630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.
    Pizzolanti G; Russo L; Richiusa P; Bronte V; Nuara RB; Rodolico V; Amato MC; Smeraldi L; Sisto PS; Nucera M; Bommarito A; Citarrella R; Lo Coco R; Cabibi D; Lo Coco A; Frasca F; Gulotta G; Latteri MA; Modica G; Galluzzo A; Giordano C
    Thyroid; 2007 Nov; 17(11):1109-15. PubMed ID: 17727338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
    Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RET/PTC rearrangement occurring in primary peritoneal carcinoma.
    Flavin R; Jackl G; Finn S; Smyth P; Ring M; O'Regan E; Cahill S; Unger K; Denning K; Jinghuan Li ; Aherne S; Tallini G; Gaffney E; O'Leary JJ; Zitzelsberger H; Sheils O
    Int J Surg Pathol; 2009 Jun; 17(3):187-97. PubMed ID: 19147513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
    Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
    Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of carcinogenic chromosomal rearrangements in human thyroid cells after induction of double-strand DNA breaks by restriction endonucleases.
    Evdokimova V; Gandhi M; Rayapureddi J; Stringer JR; Nikiforov YE
    Endocr Relat Cancer; 2012 Jun; 19(3):271-81. PubMed ID: 22323563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma].
    Zhu XL; Zhou XY; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):270-4. PubMed ID: 16181547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
    Zhu Z; Ciampi R; Nikiforova MN; Gandhi M; Nikiforov YE
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3603-10. PubMed ID: 16772343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.